The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
Title:
The orally active melanocortin-4 receptor antagonist BL-6020/979: a promising candidate for the treatment of cancer cachexia
Author:
Dallmann, R. Weyermann, P. Anklin, C. Boroff, M. Bray-French, K. Cardel, B. Courdier-Fruh, I. Deppe, H. Dubach-Powell, J. Erb, M. Haefeli, R. H. Henneböhle, M. Herzner, H. Hufschmid, M. Marks, D. L. Nordhoff, S. Papp, M. Rummey, C. Santos, G. Schärer, F. Siendt, H. Soeberdt, M. Sumanovski, L. T. Terinek, M. Mondadori, C. Güven, N. Feurer, A.